A double-blind, placebo-controlled trial of Zoloft's [sertraline] effects on symptoms and survival time in advanced cancer.
Phase of Trial: Phase III
Latest Information Update: 15 Jun 2016
At a glance
- Drugs Sertraline (Primary)
- Indications Cancer
- Focus Adverse reactions
- Acronyms ZEST
- 08 Jul 2011 New source identified and integrated (Australian New Zealand Clinical Trials Registry).
- 11 Aug 2009 Pfizer added as trial sponsor and additional trial location (Australia) identified ISRCTN: Current Controlled Trials record.
- 13 Jul 2007 Status change